Sales & Marketing Deep Dive: Commercialisation 2024 In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
